Kymera Therapeutics, Inc. KYMR
NASDAQ · United States · Health Technology
$116.12+4.33 (+3.87%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.62 | -0.71 | +13.0% | $65.00M | +98.3% | +1.9%$104.39→$106.41 |
| Q1 2026 | 2026-04-30 | -0.71 | -0.89 | +20.2% | — | — | -1.0%$81.51→$80.71 |
| Q4 2025 | 2026-02-26 | -0.97 | -0.77 | -26.0% | — | — | +0.7%$90.68→$91.35 |
| Q3 2025 | 2025-11-04 | -0.90 | -0.71 | -26.8% | — | — | +0.3%$59.72→$59.89 |
| Q2 2025 | 2025-08-11 | -0.95 | -0.80 | -18.7% | — | — | — |
| Q1 2025 | 2025-05-09 | -0.82 | -0.91 | +9.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.